FDA Inspection
Novo Nordisk A/S - 25a-BFDA Inspection 909374 - Novo Nordisk A/S - 25a-B - October 10, 2014
Record Details
This FDA Inspection record concerns Novo Nordisk A/S - 25a-B, with an inspection on October 10, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Novo Nordisk A/S - 25a-B
- Inspection Date
- October 10, 2014
- Product Type
- Drugs
View Company Profile
ID · fdfdb519-3bb2-4a70-9cb0-87607bf74333
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 909374
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Novo Nordisk A/S - 25a-B
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2023 | Not classified | Office of Inspections and Investigations | |
| November 4, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 14, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 22, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 18, 2015 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Novo Nordisk A/S - 25a-B
- FDA Inspection 1223821 - 2023-11-07
- FDA Inspection 1207487 - 2022-11-04
- FDA Inspection 1118196 - 2018-06-14
- FDA Inspection 957571 - 2016-01-22
- FDA Inspection 933969 - 2015-06-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.